Hypertension Medication Paper

1512 Words7 Pages
Modeling the Determinant of Access to Hypertension Medication: Using a Multinomial Logistic Regression
In the fourth reviewed on the impact of hypertension treatment to low­income groups, and the challenges this medical cost posed to them. A federal qualified health center (FQHC) in Michigan provides care to the medically underserved and people in the low­income group. This center sampled 212 of their patients and looked at their history of having hypertension or currently has hypertension. It shows that the FQHC had a high percentage of patients who had an uncontrolled blood pressure. The high percentage of patients with uncontrolled high blood pressure at the FQHC could be attributed to the fact that the patients cannot afford the treatment
…show more content…
The odds ratio for not knowing whether medical cost had an impact on one’s ability seeing a doctor compared to seeing a doctor disregard less of the cost were: 0.084 for having high blood pressure, ­0.345 for education level, 0.0082 for the income level, 0.026 for gender, 0.089 for race and ­0.013 for the respondents age. Table 3: Akaike Information and Bayesian Information…show more content…
The uninsured patients of hypertension are less likely to report having hypertension because they cannot afford to seek a healthcare provider and if they access the doctor then they were not able to meet the drug prescription cost. This situation makes the uninsured patients to be more prone to unawareness of their health condition. Despite the benefits that accompany the treatment of hypertension, the overall cost of treatment is overwhelming. The cost of the treatment and the cost of the pharmaceutical products needed are relatively high. Improving policies that encourage cost effectiveness may improve treatment of these disorders. Additionally it may maintain equity as the costs of medication and medication can be predetermined. Several measures may improve better health to individuals. They include insuring with privately run and public medical insurance institutions. They include Medicare and Medicaid. Insured non­elderly individuals, compared with uninsured individuals showed a greater potential of receiving drug therapy. This is the case in the elder insured and uninsured. Age and gender had a significant impact on one’s ability to access medical cost and care if they were diagnosed with
Get Access